Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen

Journal of Immunology

Volumn 190, Issue 9, 2013, Pages 4887-4898

  Cha, Soung Chul ^a   Qin, Hong ^a   Kannan, Shibichakravarthy ^a   Rawal, Seema ^a   Watkins, Leticia S ^b   Baio, Flavio E ^a   Wu, Weiguo ^a   Ong, Juliana ^a   Wei, Jinsong ^a   Kwak, Benjamin ^a   Kim, Sang ^a   Popescu, Michael S ^a   Paick, Daniel S ^a   Kim, Kunhwa ^a   Luong, Amber ^c   Davis, Richard E ^a   Schroeder, Harry W ^b   Kwak, Larry W ^a   Neelapu, Sattva S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; B LYMPHOCYTE RECEPTOR; BREAKPOINT CLUSTER REGION PROTEIN; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; VIMENTIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING COMPETITION; BINDING SITE; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; HEP 2 CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MANTLE CELL LYMPHOMA; MOLECULAR PATHOLOGY; MOLECULAR RECOGNITION; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; TUMOR MICROENVIRONMENT;

EID: 84876798571     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300179     Document Type: Article

References (48)

1. Tsujimoto, Y., J. Cossman, E. Jaffe, and C. M. Croce. 1985. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1443. (Pubitemid 15041322)
2. Tsujimoto, Y., J. Gorham, J. Cossman, E. Jaffe, and C. M. Croce. 1985. The t(14; 18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229: 1390-1393. (Pubitemid 16222379)
3. Limpens, J., R. Stad, C. Vos, C. de Vlaam, D. de Jong, G. J. van Ommen, E. Schuuring, and P. M. Kluin. 1995. Lymphoma-associated translocation t(14; 18) in blood B cells of normal individuals. Blood 85: 2528-2536.
4. Roulland, S., J. M. Navarro, P. Grenot, M. Milili, J. Agopian, B. Montpellier, P. Gauduchon, P. Lebailly, C. Schiff, and B. Nadel. 2006. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J. Exp. Med. 203: 2425-2431. (Pubitemid 44664612)
5. Dölken, G., L. Dölken, C. Hirt, C. Fusch, C. S. Rabkin, and F. Schüler. 2008. Age-dependent prevalence and frequency of circulating t(14;18)-positive cells in the peripheral blood of healthy individuals. J. Natl. Cancer Inst. Monogr. 2008: 44-47.
6. McDonnell, T. J., and S. J. Korsmeyer. 1991. Progression from lymphoid hy-perplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 349: 254-256. (Pubitemid 21912060)
7. Küppers, R. 2005. Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 5: 251-262. (Pubitemid 40488631)
8. Harris, N. L., E. S. Jaffe, H. Stein, P. M. Banks, J. K. Chan, M. L. Cleary, G. Delsol, C. De Wolf-Peeters, B. Falini, K. C. Gatter, et al. 1994. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84: 1361-1392. (Pubitemid 24273002)
9. Aarts, W. M., R. J. Bende, E. J. Steenbergen, P. M. Kluin, E. C. Ooms, S. T. Pals, and C. J. van Noesel. 2000. Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load. Blood 95: 2922-2929. (Pubitemid 30235904)
10. Bahler, D. W., and R. Levy. 1992. Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc. Natl. Acad. Sci. USA 89: 6770-6774.
11. Irish, J. M., D. K. Czerwinski, G. P. Nolan, and R. Levy. 2006. Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. Blood 108: 3135-3142.
12. Dighiero, G., S. Hart, A. Lim, L. Borche, R. Levy, and R. A. Miller. 1991. Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas. Blood 78: 581-585.
13. Wardemann, H., S. Yurasov, A. Schaefer, J. W. Young, E. Meffre, and M. C. Nussenzweig. 2003. Predominant autoantibody production by early human B cell precursors. Science 301: 1374-1377. (Pubitemid 37075812)
14. Freedman, A., S. S. Neelapu, C. Nichols, M. J. Robertson, B. Djulbegovic, J. N. Winter, J. F. Bender, D. P. Gold, R. G. Ghalie, M. E. Stewart, et al. 2009. Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma. J. Clin. Oncol. 27: 3036-3043.
15. Neelapu, S. S., S. Baskar, B. L. Gause, C. B. Kobrin, T. M. Watson, A. R. Frye, R. Pennington, L. Harvey, E. S. Jaffe, R. J. Robb, et al. 2004. Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen. Clin. Cancer Res. 10: 8309-8317. (Pubitemid 40053391)
16. Neelapu, S. S., L. W. Kwak, C. B. Kobrin, C. W. Reynolds, J. E. Janik, K. Dunleavy, T. White, L. Harvey, R. Pennington, M. Stetler-Stevenson, et al. 2005. Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma. Nat. Med. 11: 986-991. (Pubitemid 41294445)
17. Neelapu, S. S., N. C. Munshi, S. Jagannath, T. M. Watson, R. Pennington, C. Reynolds, B. Barlogie, and L. W. Kwak. 2005. Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma. Bone Marrow Transplant. 36: 315-323. (Pubitemid 41195164)
18. Bendandi, M., C. D. Gocke, C. B. Kobrin, F. A. Benko, L. A. Sternas, R. Pennington, T. M. Watson, C. W. Reynolds, B. L. Gause, P. L. Duffey, et al. 1999. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat. Med. 5: 1171-1177. (Pubitemid 29474422)
19. Carroll, W. L., K. Thielemans, J. Dilley, and R. Levy. 1986. Mouse 3 human heterohybridomas as fusion partners with human B cell tumors. J. Immunol. Methods 89: 61-72. (Pubitemid 16079581)
20. Redfern, C. H., T. H. Guthrie, A. Bessudo, J. J. Densmore, P. R. Holman, N. Janakiraman, J. P. Leonard, R. L. Levy, R. G. Just, M. R. Smith, et al. 2006. Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses. J. Clin. Oncol. 24: 3107-3112. (Pubitemid 46638948)
21. Giudicelli, V., D. Chaume, and M. P. Lefranc. 2004. IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res. 32: W435-W40.
22. Zhu, D., H. McCarthy, C. H. Ottensmeier, P. Johnson, T. J. Hamblin, and F. K. Stevenson. 2002. Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood 99: 2562-2568. (Pubitemid 34525446)
23. + memory B cells. Immunity 26: 205-213. (Pubitemid 46329436)
24. + memory B cell development. J. Exp. Med. 203: 393-400. (Pubitemid 43290848)
25. Zemlin, M., M. Klinger, J. Link, C. Zemlin, K. Bauer, J. A. Engler, H. W. Schroeder, Jr., and P. M. Kirkham. 2003. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J. Mol. Biol. 334: 733-749. (Pubitemid 37433888)
26. Ivanov, I. I., R. L. Schelonka, Y. Zhuang, G. L. Gartland, M. Zemlin, and H. W. Schroeder, Jr. 2005. Development of the expressed Ig CDR-H3 repertoire is marked by focusing of constraints in length, amino acid use, and charge that are first established in early B cell progenitors. J. Immunol. 174: 7773-7780. (Pubitemid 40806284)
27. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157: 105-132.
28. Eisenberg, D. 1984. Three-dimensional structure of membrane and surface proteins. Annu. Rev. Biochem. 53: 595-623.
29. Bende, R. J., L. A. Smit, and C. J. van Noesel. 2007. Molecular pathways in follicular lymphoma. Leukemia 21: 18-29. (Pubitemid 44921830)
30. Hervé, M., K. Xu, Y. S. Ng, H. Wardemann, E. Albesiano, B. T. Messmer, N. Chiorazzi, and E. Meffre. 2005. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J. Clin. Invest. 115: 1636-1643. (Pubitemid 40814672)
31. Sachen, K. L., M. J. Strohman, J. Singletary, A. A. Alizadeh, N. H. Kattah, C. Lossos, E. D. Mellins, S. Levy, and R. Levy. 2012. Self-antigen recognition by follicular lymphoma B-cell receptors. Blood 120: 4182-4190.
32. Irish, J. M., J. H. Myklebust, A. A. Alizadeh, R. Houot, J. P. Sharman, D. K. Czerwinski, G. P. Nolan, and R. Levy. 2010. B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression. Proc. Natl. Acad. Sci. USA 107: 12747-12754.
33. Lanemo Myhrinder, A., E. Hellqvist, E. Sidorova, A. Söderberg, H. Baxendale, C. Dahle, K. Willander, G. Tobin, E. Bäckman, O. Söderberg, et al. 2008. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood 111: 3838-3848.
34. Ghiotto, F., F. Fais, A. Valetto, E. Albesiano, S. Hashimoto, M. Dono, H. Ikematsu, S. L. Allen, J. Kolitz, K. R. Rai, et al. 2004. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J. Clin. Invest. 113: 1008-1016. (Pubitemid 38544122)
35. Bende, R. J., W. M. Aarts, R. G. Riedl, D. de Jong, S. T. Pals, and C. J. van Noesel. 2005. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J. Exp. Med. 201: 1229-1241. (Pubitemid 40629067)
36. Chu, C. C., R. Catera, K. Hatzi, X. J. Yan, L. Zhang, X. B. Wang, H. M. Fales, S. L. Allen, J. E. Kolitz, K. R. Rai, and N. Chiorazzi. 2008. Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize non-muscle myosin heavy chain IIA. Blood 112: 5122-5129.
37. Matsui, W., C. A. Huff, Q. Wang, M. T. Malehorn, J. Barber, Y. Tanhehco, B. D. Smith, C. I. Civin, and R. J. Jones. 2004. Characterization of clonogenic multiple myeloma cells. Blood 103: 2332-2336. (Pubitemid 38326254)
38. Blaschek, M. A., M. Boehme, J. Jouquan, A. M. Simitzis, S. Fifas, P. Le Goff, and P. Youinou. 1988. Relation of antivimentin antibodies to anticardiolipin antibodies in systemic lupus erythematosus. Ann. Rheum. Dis. 47: 708-716.
39. Ortona, E., A. Capozzi, T. Colasanti, F. Conti, C. Alessandri, A. Longo, T. Garofalo, P. Margutti, R. Misasi, M. A. Khamashta, et al. 2010. Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome. Blood 116: 2960-2967.
40. Xu, B., R. M. deWaal, N. Mor-Vaknin, C. Hibbard, D. M. Markovitz, and M. L. Kahn. 2004. The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature. Mol. Cell. Biol. 24: 9198-9206. (Pubitemid 39313921)
41. Mor-Vaknin, N., A. Punturieri, K. Sitwala, and D. M. Markovitz. 2003. Vimentin is secreted by activated macrophages. Nat. Cell Biol. 5: 59-63. (Pubitemid 36054330)
42. Huet, D., M. Bagot, D. Loyaux, J. Capdevielle, L. Conraux, P. Ferrara, A. Bensussan, and A. Marie-Cardine. 2006. SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells. J. Immunol. 176: 652-659. (Pubitemid 43023314)
43. Garg, A., P. F. Barnes, A. Porgador, S. Roy, S. Wu, J. S. Nanda, D. E. Griffith, W. M. Girard, N. Rawal, S. Shetty, and R. Vankayalapati. 2006. Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor. J. Immunol. 177: 6192-6198. (Pubitemid 44628837)
44. Moisan, E., and D. Girard. 2006. Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis. J. Leukoc. Biol. 79: 489-498. (Pubitemid 44831226)
45. Leong, H. S., B. M. Mahesh, J. R. Day, J. D. Smith, A. D. McCormack, G. Ghimire, T. J. Podor, and M. L. Rose. 2008. Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor. J. Leukoc. Biol. 83: 263-271. (Pubitemid 351225606)
46. Bryant, A. E., C. R. Bayer, J. D. Huntington, and D. L. Stevens. 2006. Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes. J. Infect. Dis. 193: 1685-1692. (Pubitemid 43839473)
47. Nijenhuis, S., A. J. Zendman, E. R. Vossenaar, G. J. Pruijn, and W. J. vanVenrooij. 2004. Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Clin. Chim. Acta 350: 17-34. (Pubitemid 39458243)
48. Marceau, N., B. Schutte, S. Gilbert, A. Loranger, M. E. Henfling, J. L. Broers, J. Mathew, and F. C. Ramaekers. 2007. Dual roles of intermediate filaments in apoptosis. Exp. Cell Res. 313: 2265-2281. (Pubitemid 46842976)